Cargando…

Non-inflammatory pain in inflammatory arthritis

‘Non-inflammatory’ pain, pain that is not associated with measures of inflammation, is common in patients with inflammatory arthritis including RA. One important cause of non-inflammatory pain is concomitant fibromyalgia. Systematic review has shown that fibromyalgia is common in inflammatory arthri...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Dhivya, Choy, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321089/
https://www.ncbi.nlm.nih.gov/pubmed/36478185
http://dx.doi.org/10.1093/rheumatology/keac671
_version_ 1785068559236333568
author Das, Dhivya
Choy, Ernest
author_facet Das, Dhivya
Choy, Ernest
author_sort Das, Dhivya
collection PubMed
description ‘Non-inflammatory’ pain, pain that is not associated with measures of inflammation, is common in patients with inflammatory arthritis including RA. One important cause of non-inflammatory pain is concomitant fibromyalgia. Systematic review has shown that fibromyalgia is common in inflammatory arthritis including RA affecting 1 in 5 patients and is associated with higher disease activity scores due to inflated tender joint count and patient global assessment. Consequently, many patients with RA and concomitant fibromyalgia may fail to reach treatment target and switch to alternate disease modifying drugs frequently. European Alliance of Association for Rheumatology has highlighted that concomitant fibromyalgia is an important consideration in assessing difficult-to-treat RA. The incidence and prevalence of fibromyalgia are higher in RA than the general population, raising the possibility that fibromyalgia may be ‘secondary’ to RA rather than a concomitant disease. The precise mechanisms whereby patients with RA develop fibromyalgia are unknown. In this review, we discussed fibromyalgia in RA, its clinical impact and epidemiology as well as data suggesting fibromyalgia might be ‘secondary’. Lastly, we reviewed potential pathogenic mechanisms which included inflammatory cytokines sensitizing nociceptive neurones, temporal summation, also known as windup, from chronic pain and impaired coping from poor quality sleep and mental well-being. Deciphering the exact mechanisms may lead to treatment strategies that prevent development of secondary fibromyalgia and will address a common factor associated with difficult-to-treat RA.
format Online
Article
Text
id pubmed-10321089
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103210892023-07-06 Non-inflammatory pain in inflammatory arthritis Das, Dhivya Choy, Ernest Rheumatology (Oxford) Reviews ‘Non-inflammatory’ pain, pain that is not associated with measures of inflammation, is common in patients with inflammatory arthritis including RA. One important cause of non-inflammatory pain is concomitant fibromyalgia. Systematic review has shown that fibromyalgia is common in inflammatory arthritis including RA affecting 1 in 5 patients and is associated with higher disease activity scores due to inflated tender joint count and patient global assessment. Consequently, many patients with RA and concomitant fibromyalgia may fail to reach treatment target and switch to alternate disease modifying drugs frequently. European Alliance of Association for Rheumatology has highlighted that concomitant fibromyalgia is an important consideration in assessing difficult-to-treat RA. The incidence and prevalence of fibromyalgia are higher in RA than the general population, raising the possibility that fibromyalgia may be ‘secondary’ to RA rather than a concomitant disease. The precise mechanisms whereby patients with RA develop fibromyalgia are unknown. In this review, we discussed fibromyalgia in RA, its clinical impact and epidemiology as well as data suggesting fibromyalgia might be ‘secondary’. Lastly, we reviewed potential pathogenic mechanisms which included inflammatory cytokines sensitizing nociceptive neurones, temporal summation, also known as windup, from chronic pain and impaired coping from poor quality sleep and mental well-being. Deciphering the exact mechanisms may lead to treatment strategies that prevent development of secondary fibromyalgia and will address a common factor associated with difficult-to-treat RA. Oxford University Press 2022-12-07 /pmc/articles/PMC10321089/ /pubmed/36478185 http://dx.doi.org/10.1093/rheumatology/keac671 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Reviews
Das, Dhivya
Choy, Ernest
Non-inflammatory pain in inflammatory arthritis
title Non-inflammatory pain in inflammatory arthritis
title_full Non-inflammatory pain in inflammatory arthritis
title_fullStr Non-inflammatory pain in inflammatory arthritis
title_full_unstemmed Non-inflammatory pain in inflammatory arthritis
title_short Non-inflammatory pain in inflammatory arthritis
title_sort non-inflammatory pain in inflammatory arthritis
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321089/
https://www.ncbi.nlm.nih.gov/pubmed/36478185
http://dx.doi.org/10.1093/rheumatology/keac671
work_keys_str_mv AT dasdhivya noninflammatorypainininflammatoryarthritis
AT choyernest noninflammatorypainininflammatoryarthritis